Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates Quince Therapeutics (NASDAQ:QNCX) wit

Quince Therapeutics (NASDAQ:QNCX) reported quarterly losses of $(12.31) per share which beat the ana

Oppenheimer analyst Mazahir Alimohamed initiates coverage on Quince Therapeutics (NASDAQ:QNCX) wi

Leerink Partners analyst Joseph Schwartz initiates coverage on Quince Therapeutics (NASDAQ:QNCX)

Cantor Fitzgerald analyst Olivia Brayer Saunders initiates coverage on Quince Therapeutics (NASDA

The acquisition is structured as a stock-for-stock merger, pursuant to which all outstanding equity

Data from Phase 2a study of LAM-001 on top of standard of care in PH-ILD patients with refractory PH

US stocks rose, Dow up 2.85%, Nasdaq up 3.33%, S&P 500 up 2.54%. Consumer discretionary shares u

Levi Strauss (LEVI) reported strong Q1 2026 results, raising revenue & earnings guidance. Other

Quince Therapeutics, Inc. (Nasdaq: QNCX) today announced the successful settlement of the company&#3

Quince Therapeutics shares surged 53% after hours Thursday following the engagement of LifeSci Capit

Quince Therapeutics stock is trading sharply lower Thursday after the biotech company followed up We

Quince Therapeutics is soaring again on Wednesday as the company has engaged LifeSci Capital to expl

QNCX, SPOT, SPGI, INTC, DDOG were among the stocks trending among investors on Tuesday, Feb. 10, 202

Quince Therapeutics Inc shares are soaring Tuesday as the company has engaged LifeSci Capital to ser

Quince Therapeutics (NASDAQ: QNCX) engages LifeSci as financial advisor to explore strategic alterna

Quince Therapeutics, Inc. (Nasdaq: QNCX), today announced that it has engaged LifeSci Capital to ser